Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03755518 |
|---|---|
| Brief Title: | A Trial of Fedratinib in Subjects With DIPSS, Intermediate or High-Risk Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis and Previously Treated With Ruxolitinib (FREEDOM) |
| First Submitted : | November 8, 2018 |
| First Submitted that Met QC Criteria : | November 26, 2018 |
| First Posted : | November 28, 2018 |
| Last Update Submitted that Met QC Criteria : | May 10, 2022 |
| Last Update Posted : | May 16, 2022 |